Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction
Open Access
- 1 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 5 (1) , 63-71
- https://doi.org/10.1161/circheartfailure.111.963462
Abstract
Background—: We aimed to develop a multivariable statistical model for risk stratification in patients with chronic heart failure with systolic dysfunction, using patient data that are routinely collected and easily obtained at the time of initial presentation. Methods and Results—: In a cohort of 2331 patients enrolled in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise TraiNing) study (New York Heart Association class II–IV, left ventricular ejection fraction ≤0.35, randomized to exercise training and usual care versus usual care alone, median follow-up of 2.5 years), we performed risk modeling using Cox proportional hazards models and analyzed the relationship between baseline clinical factors and the primary composite end point of death or all-cause hospitalization and the secondary end point of all-cause death alone. Prognostic relationships for continuous variables were examined using restricted cubic spline functions, and key predictors were identified using a backward variable selection process and bootstrapping methods. For ease of use in clinical practice, point-based risk scores were developed from the risk models. Exercise duration on the baseline cardiopulmonary exercise test was the most important predictor of both the primary end point and all-cause death. Additional important predictors for the primary end point risk model (in descending strength) were Kansas City Cardiomyopathy Questionnaire symptom stability score, higher serum urea nitrogen, and male sex (all P P <0.0001). Conclusions—: Risk models using simple, readily obtainable clinical characteristics can provide important prognostic information in ambulatory patients with chronic heart failure with systolic dysfunction. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00047437.Keywords
This publication has 35 references indexed in Scilit:
- Application of the Seattle Heart Failure Model in Ambulatory Patients Presented to an Advanced Heart Failure Therapeutics CommitteeCirculation: Heart Failure, 2010
- Effects of Exercise Training on Health Status in Patients With Chronic Heart FailureJAMA, 2009
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureJAMA, 2009
- Predictors of fatal and non‐fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A‐1, high‐sensitivity C‐reactive peptide and N‐terminal pro B‐type natriuretic peptideEuropean Journal of Heart Failure, 2009
- Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patientsQuality of Life Research, 2007
- Prospective Comparison of Ventilatory Equivalent Versus Peak Oxygen Consumption in Predicting Outcomes of Patients With Heart FailureThe American Journal of Cardiology, 2006
- Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-BlockersCirculation, 2005
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004
- Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure ∗The American Journal of Cardiology, 2000
- Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart FailureJournal of the American College of Cardiology, 1996